Arcturus Therapeutics Correlations

ARCT
 Stock
  

USD 16.16  0.42  2.67%   

The correlation of Arcturus Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arcturus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arcturus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please continue to Trending Equities.
  
Refresh
The ability to find closely correlated positions to Arcturus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arcturus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arcturus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arcturus Therapeutics to buy it.

Moving together with Arcturus Therapeutics

0.89AADIAadi BiosciencesPairCorr
0.93ABCMAbcam Plc ADRPairCorr
0.91ABEOAbeona TherapeuticsPairCorr
0.91ABSIAbsci CorpPairCorr
0.62ABUSArbutus BiopharmaPairCorr
0.76ABVCAbvc BiopharmaPairCorr
0.9ACADAcadia PharmaceuticaPairCorr
0.78ACERAcer TherapeuticsPairCorr
0.87ACETAdicet BioPairCorr
0.68ACHLAchilles Therapeutics PlcPairCorr
0.78ACHVAchieve Life SciencesPairCorr
0.86ACIUAC Immune SAPairCorr
0.85ACORAcorda TherapeuticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
UBERMSFT
FMSFT
CRMMSFT
JPMA
JPMF
  
High negative correlations   

Arcturus Therapeutics Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Arcturus Therapeutics stock performing well and Arcturus Therapeutics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Arcturus Therapeutics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.81  0.10  0.05 (0.01)  3.51  0.04 (2.99)  5.66 (5.40)  36.79 
MSFT 1.92  0.00  0.00 (0.19)  0.00 (0.0357)  0.00  2.97 (4.24)  9.36 
UBER 3.35 (0.41)  0.00 (0.42)  0.00 (0.14)  0.00  6.32 (7.19)  18.56 
F 2.40 (0.33)  0.00 (0.40)  0.00 (0.15)  0.00  3.68 (5.54)  16.83 
T 1.31  0.40  0.28  0.41  1.37  0.26 (1.50)  2.99 (2.47)  12.17 
A 1.98  0.03  0.00 (0.17)  0.00 (0.0044)  0.00  3.19 (3.50)  9.78 
CRM 2.64 (0.04)  0.00 (0.21)  0.00 (0.05)  0.00  6.33 (5.28)  16.84 
JPM 1.46 (0.10)  0.00 (0.29)  0.00 (0.06)  0.00  2.98 (3.00)  10.78 
MRK 1.08  0.30  0.34  0.40  0.99  0.28 (1.26)  2.16 (1.65)  7.61 
XOM 1.96  0.31  0.10  0.14  2.96  0.13 (1.71)  3.03 (3.96)  11.86 

Similar Equity Warning - ARCT

Arcturus Therapeutics was forked

The entity Arcturus Therapeutics with a symbol ARCT was recently forked. You can potentially use AMERICAN REALTY CAPITAL with a symbol ARCT1 from now on.

Arcturus Therapeutics Corporate Directors

Arcturus Therapeutics corporate directors refer to members of an Arcturus Therapeutics board of directors. The board of directors generally takes responsibility for the Arcturus Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arcturus Therapeutics' board members must vote for the resolution. The Arcturus Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Investing Arcturus Therapeutics

You need to understand the risk of investing before taking a position in Arcturus Therapeutics. The danger of trading Arcturus Therapeutics is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arcturus Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arcturus Therapeutics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arcturus Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Arcturus Stock analysis

When running Arcturus Therapeutics price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
426.9 M
Quarterly Revenue Growth YOY
1.47
Return On Assets
-0.3
Return On Equity
-0.74
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Arcturus Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.